{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "shortName": "PCI BIOTECH ASA  NK 3", "messageBoardId": "finmb_45308758", "exchangeTimezoneShortName": "CEST", "market": "dr_market", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "longName": "PCI Biotech Holding ASA", "regularMarketChangePercent": -0.40816003, "regularMarketPrice": 0.1464, "exchangeTimezoneName": "Europe/Berlin", "marketState": "REGULAR", "regularMarketChange": -0.00059999526, "regularMarketTime": 1683871386, "regularMarketDayHigh": 0.1464, "regularMarketDayRange": "0.1464 - 0.1464", "regularMarketDayLow": 0.1464, "regularMarketVolume": 685, "regularMarketPreviousClose": 0.147, "bid": 0.147, "ask": 0.1838, "fullExchangeName": "Frankfurt", "financialCurrency": "NOK", "regularMarketOpen": 0.1464, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.035800003, "fiftyTwoWeekLowChangePercent": 0.32368898, "fiftyTwoWeekRange": "0.1106 - 0.54", "fiftyTwoWeekHighChange": -0.39360002, "fiftyTwoWeekHighChangePercent": -0.72888887, "fiftyTwoWeekLow": 0.1106, "fiftyTwoWeekHigh": 0.54, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.12, "sharesOutstanding": 37326400, "bookValue": 1.538, "fiftyDayAverage": 0.147616, "fiftyDayAverageChange": -0.0012159944, "fiftyDayAverageChangePercent": -0.008237551, "twoHundredDayAverage": 0.184199, "twoHundredDayAverageChange": -0.037799, "twoHundredDayAverageChangePercent": -0.20520741, "marketCap": 6762040, "priceToBook": 0.09518856, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1223445600000, "priceHint": 4, "symbol": "4QG.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "UllernchaussEen 64", "city": "Oslo", "zip": "0379", "country": "Norway", "phone": "47 67 11 54 00", "website": "https://www.pcibiotech.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ronny  Skuggedal", "age": 46, "title": "CEO & CFO", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anders  Hogset Ph.D.", "age": 68, "title": "Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kristin  Eivindvik", "age": 61, "title": "Chief Devel. Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}